Condition
Pharmacogenomic Testing
Total Trials
4
Recruiting
1
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Active Not Recruiting2
Recruiting1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05091879Not ApplicableActive Not Recruiting
Preemptive Pharmacogenomics Testing Among Geriatric Patients
NCT05037305Not ApplicableActive Not RecruitingPrimary
VICE-MPRINT: Maternal and Pediatric Pharmacogenetics Survey
NCT07216846Not ApplicableRecruiting
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
NCT05247814Not Yet Recruiting
Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
Showing all 4 trials